Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $167 million versus the consensus estimate of $158.54 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.